| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 1,291 | -129 | -108 | 374 |
| Net loss | -32,733 | -26,882 | -21,529 | -25,524 |
| Earnings per share, basic, total | -0.09 | -0.09 | -0.08 | -0.1 |
| Earnings per share, diluted, total | -0.09 | -0.09 | -0.08 | -0.1 |
| Weighted average number of shares outstanding, basic, total | 353,309,524 | 297,988,978 | 269,306,331 | 267,824,045 |
| Weighted average number of shares outstanding, diluted, total | 353,309,524 | 297,988,978 | 269,306,331 | 267,824,045 |
Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. (TSHA)